Sign in

    Julien [on for Liisa Bayko]

    Senior Managing Director at Evercore ISI

    Julian Emanuel is a Senior Managing Director at Evercore ISI, specializing in equity and derivatives research with a strong focus on strategy across U.S. equities and related markets. He covers major companies in diverse sectors including technology, consumer, and industrials, and is recognized for providing actionable market insights and high-quality macro and micro analysis. Emanuel began his current role in December 2021 after several years as Managing Director and Chief Equity and Derivatives Strategist, holding prior senior positions with major financial institutions and bringing over 15 years of experience in investment banking and financial services. He holds an MBA from NYU Stern School of Business and a BBA from Emory University, with credentials including relevant securities licenses and FINRA registrations.

    Julien [on for Liisa Bayko]'s questions to Editas Medicine (EDIT) leadership

    Julien [on for Liisa Bayko]'s questions to Editas Medicine (EDIT) leadership • Q3 2023

    Question

    Asked for the expected timing of a legal appeal decision, when to expect a substantial data update for TDT patients, and when the company will communicate the outcome of its regulatory path discussions with the FDA.

    Answer

    The company declined to comment on ongoing legal proceedings. They confirmed strong enrollment in the TDT trial but have not yet provided a timeline for a substantial data update. They will share the outcome of FDA discussions at an appropriate future time.

    Ask Fintool Equity Research AI